Coronavirus

Originally Posted by papa smurf

It's very reassuring to know that you're googling everything I post.

Not everything - just the completely wrong statements*.


*OK, that’s nearly everything...

Apparently our local area has been declared 'suppressed' of coronavirus.
This is because we had less than 3 cases reported in the previous week (Nov 20 - 27).

We have almost the lowest rate per 100,000 in all of Nottinghamshire.

So of course, we are in T3.

[Pierre]

Originally Posted by Paul

Apparently our local area has been declared 'suppressed' of coronavirus.
This is because we had less than 3 cases reported in the previous week (Nov 20 - 27).

We have almost the lowest rate per 100,000 in all of Nottinghamshire.

So of course, we are in T3.

If only Parliament sat in Nottingham, you’d be dining out tonight.

[Halcyon]

Quite disappointed the Oxford Vaccine seems to have been put on hold in favor of others. This seemed like the best choice in my opinion and many doctors think the same too.

[BenMcr]

Originally Posted by Halcyon

Quite disappointed the Oxford Vaccine seems to have been put on hold in favor of others. This seemed like the best choice in my opinion and many doctors think the same too.

It's not on hold as far as I'm aware, but it's not as far down the testing path as the others. So it hasn't yet been approved

https://www.mirror.co.uk/news/politi...roved-23123004

The Oxford/AstraZeneca coronavirus vaccine may be approved for use in the UK as soon as Christmas, Matt Hancock has claimed.

The Health Secretary suggested the jab could follow the Pfizer/BioNTech vaccine, and become the second to get the green light from the Medicines and Healthcare products Regulatory Agency (MHRA).

Also there is the issue about the half dose / full dose effectiveness that they're trialling properly now.

Originally Posted by Halcyon

Quite disappointed the Oxford Vaccine seems to have been put on hold in favor of others. This seemed like the best choice in my opinion and many doctors think the same too.

It definitely isn't on hold. its developers are continuing to do the necessary work to get it ready to send to the regulator for approval. The Oxford vaccine has always been slightly behind the Pfizer and Moderna vaccines in trial progress. The Pfizer vaccine is rolling out today because it is ready today (and is still the only one that is both ready and in receipt of regulatory approval).

So it begins ... those who do pub quizzes take note, Mrs Keenan’s name will be required of you as soon as you’re allowed back in your local. Which may not be too long away now.

https://www.bbc.co.uk/news/uk-55227325

A 90-year-old woman has become the first person to be given a Covid jab as part of the mass vaccination programme being rolled out across the UK.
Margaret Keenan, who turns 91 next week, said it was the "best early birthday present".
She was given the injection at 06:31 GMT - the first of 800,000 doses of the Pfizer/BioNTech vaccine that will be given in the coming weeks.
Up to four million more are expected by the end of the month.
Hubs in the UK will vaccinate over-80s and some health and care staff - the programme aims to protect the most vulnerable and return life to normal.
Matron May Parsons administered Ms Keenan's vaccine at University Hospital in Coventry.

[1andrew1]

Originally Posted by Chris

So it begins ... those who do pub quizzes take note, Mrs Keenan’s name will be required of you as soon as you’re allowed back in your local. Which may not be too long away now.

https://www.bbc.co.uk/news/uk-55227325

The second person to be vaccinated was William Shakespeare from Warwickshire!

The second patient to get the coronavirus vaccine jab at University Hospital Coventry has been named as William Shakespeare from Warwickshire.
He follows Margaret Keenan in becoming one of the first to receive the coronavirus Pfizer vaccine jabs in England.

https://www.birminghammail.co.uk/new...ccine-19417635

[nomadking]

Wouldn't the people who were vaccinated first have been the ones taking part in the trials?

Originally Posted by nomadking

Wouldn't the people who were vaccinated first have been the ones taking part in the trials?

They did clarify that point on the BBC news - she was the first person after Clinical Trials.

Originally Posted by nomadking

Wouldn't the people who were vaccinated first have been the ones taking part in the trials?

She’s the first patient in the vaccination programme and the first to get the approved vaccine as medicine rather than as an experiment. But yes, the first person to actually get any new pharmaceutical product is a student called Dave who finds it easier than stacking shelves to earn beer money.

@Trump_ton

"First we will obtain control of Margaret from Coventry then we get her to make everyone install Windows 10 V20H2"

This pensioner has performed an illegal operation and will be shut down. Press OK to continue.

https://t.co/OesWkMQsRC

Pfizer’s Vaccine Offers Strong Protection After First Dose

The Food and Drug Administration’s first analysis of the clinical trial data also found that the coronavirus vaccine worked well regardless of a volunteer’s race, weight or age.

WASHINGTON — The coronavirus vaccine made by Pfizer and BioNTech provides strong protection against Covid-19 within about 10 days of the first dose, according to documents published on Tuesday by the Food and Drug Administration before a meeting of its vaccine advisory group.

The finding is one of several significant new results featured in the briefing materials, which include more than 100 pages of data analyses from the agency and from Pfizer. Last month, Pfizer and BioNTech announced that their two-dose vaccine had an efficacy rate of 95 percent after two doses administered three weeks apart. The new analyses show that the protection starts kicking in far earlier.

What’s more, the vaccine worked well regardless of a volunteer’s race, weight or age. While the trial did not find any serious adverse events caused by the vaccine, many participants did experience aches, fevers and other side effects.

“This is what an A+ report card looks like for a vaccine,” said Akiko Iwasaki, an immunologist at Yale University.

The briefing materials also provide a deeper look at the safety of the vaccine. In any large clinical trial, some people who get vaccines experience health conditions that have nothing to do with the vaccine itself. Comparing their rates of symptoms with those of the placebo group as well as with background rates in a population can point to symptoms that may actually be caused by a vaccine.

The F.D.A. concluded that there were no “meaningful imbalances” in serious health complications, known as adverse events, between the two groups. The agency noted that four people in the vaccinated group experienced a form of facial paralysis called Bell’s palsy, with no cases in the placebo group. The difference between the two groups wasn’t meaningful, and the rate in the vaccinated group was not significantly higher than in the general population.

The new Pfizer analysis revealed that many volunteers who received the vaccine felt ill in the hours after the second dose, suggesting that many people might have to request a day off work or be prepared to rest until the symptoms subside. Among those between ages 16 and 55, more than half developed fatigue, and more than half also reported headaches. Just over one-third felt chills, and 37 percent felt muscle pain. About half of those over age 55 felt fatigued, one-third developed a headache and about one-quarter felt chills, while 29 percent experienced muscle pain.

“Taking a day off after the second dose is a good thing to anticipate,” Dr. Iwasaki said.

I was told the same thing about the 2nd dose I got on the trial I’m taking part in (I didn’t, so I may have had the placebo).

Meanwhile, the Oxford vaccine is found to be “safe and effective” in peer review.

https://www.bbc.co.uk/news/health-55228422

Further tests are ongoing to increase confidence in the data that suggests a half dose followed by a full dose results in 90% efficacy. They’re concerned that the small sample of people given the half dose were all under 55 years old and might have been expected to show a stronger immune response regardless.

Nonetheless the vaccine has already been put forward for emergency approval.